Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
Classes of Antidysrhythmic Drugs |
Class I: sodium channel blockers- slow it down Class II: beta blocker (block epinephirne and norepinephrine. Class III: potassium channel blocker Class IV: Calcium channel blockers- hear contracting too rapidly |
|
Antidysrhthmic Drugs |
An abnormality in the rhythm of the heartbeat. Two basic types of dysrhythmias: 1. Tachydysrhythmias: heart rate is increased 2. Bradydysrhythmias: heart rate is slowed - Dysrhythmias are also known as arrhythmias |
|
Electrical properties of the heart |
Impulse conduction: pathways and timing SA node, AV node, His |
|
SA node |
pacemaker of heart fires 60-100 times/minute |
|
AV node |
fires 40-60 times/minute |
|
His-Purkinje system |
Fires more than 40 times/minute |
|
Cardiac action potentials |
Occur in fibers of the His-Purkinje system and in atrial and ventricular muscle. There are 5 distinct phases: Phases 0, 1, 2, 3, and 4. |
|
Phase 0 |
depolarization (resting) |
|
Phase 1 |
(partial) repolarization |
|
Phase 2 |
plateau |
|
Phase 3 |
Repolarization (low cardiac output)
|
|
Phase 4 |
Stable potential |
|
The electrocardiogram |
P wave QRS complex T wave PR interval QT interval ST segment |
|
P wave |
Depolarization in the atria. The current has traveled form AV node to atria |
|
QRS complex |
Depolarization of the ventricles. Current going down bundle branches. |
|
T wave |
Repolarization of the ventricles. Ventricular filling. |
|
Gneration of Dysrhythmias |
2 fundamental causes: 1. Disturbances of automaticity 2. Disturbances of conduction -Atrioventricular block
|
|
Classification of Antidysrhythmic Drugs |
Vaughan Williams Classification Class 1: sodium channel blockers Class 2: beta blockers Class 3: potassium channel blockers Class 4: Calcium channel blockers Other: adenosine, digoxin, and ibutilide |
|
Supraventricular dysrhythmias |
Impuse arises above the ventricle Atrial flutter Atrial fibrillation Sustained supraventricular tachycardia (SVT) |
|
Multiple Varied P waves |
Atrail fibrillation. Wavy baseline and irregular rhythm. The atria is quivering. It pools and clots in the atria. |
|
Ventricular dysrhthmias |
Sustained ventricular tachycardia Ventricular fibrilation Ventricular premature beats Digoxin-induced ventricular dysrhythmias Torsades de Pointes |
|
No P wave |
Ventricular fibrillation |
|
Class I: Sodium channel Blockers |
Treat atrial and ventricular dysrhythmias Class IA agents: Quinidine Class IB agents: Lidocaine |
|
Quinidine: Effects on the heart |
Blocks sodium channels Slows impulse conduction Delays repolarization |
|
Quinidine: Effects on the ECG |
Widens the QRS complex Prolongs the QT interval Slows the rhythm |
|
Quinidine: Therapeutic uses |
Used against supraventricular and ventricular dysrhthmias |
|
Quinidine: Adverse Effects |
Diarrhea Cinchonsim Cardiotoxicity Atrerial embolism (due to atrial fibrilation) Alpha-adrenergic blockade, resulting in hypotension Hypersensitivity reactions Drug interaction: Digoxin |
|
Cinchonism |
Tinnitus, H/A, nausea, vertigo, disturbed vision |
|
Lidocaine (Xylocaine): Effects on the heart and ECG |
Blocks cardiac sodium channels Slows conduction in the atria, ventricles, and His-purkinje system Reduces automaticity in the ventricles and His-Purkinje system |
|
Lidocaine: Adverse effects |
CNS effects Drowsiness Confusion Paresthesias |
|
Paresthesias |
tingling and numbness in extremities |
|
Class II Beta blockers |
Propranolol (Inderal) Carvedilol (Coreg) |
|
Class II Beta Blockers: Propranolol (Inderal) and Carvedilol (Coreg): Effects on the heart and ECG |
Decreased automaticity of the SA node Decreased velocity of conduction through the AV node. Decreased myocardial contractility: negative inotropic effect |
|
Cass II Beta Blockers: Popranolo (inderal) and Carvedilol (Coreg) Therapeutic use |
Dysrhythmias caused by excessive sympathetic stimulation Supraventricular tachydysrhythmias: suppression of excessive discharge and slowing of heart rate |
|
Class II Beta Blockers: Propranolol (Inderal) and Carvedilol (Coreg): Adverse Effects |
Heart block Heart failure AV block Sinus arrest Hypotension Bronchospasm (in asthma patients) |
|
Class III: Potassium channel blockers- Amiodarone (Cordarone, Pacerone) Therapeutic uses |
Long term therapy for life-threatening ventricular dysrhythmias and converting atrial fibrilation to normal sinus rhythm. Recurrent ventricular fibrilation Recurrent hemodynamically unstable ventricular tachycardia |
|
Class III: Potassium channel blockers: Amiodarone (Cordarone, Pacerone) Effects on the heart and ECG |
Reduces automaticity in the SA node Reduced contractility Reduced conduction velocity QRS widening Prolongation of the PR and QT intervals |
|
Class III: Potassium Channel blockers: Amiodarone (Cordarone, Pacerone) Adverse Effects |
Pulmonary toxicity Cardiotoxicity Toxicity in pregnancy and breastfeeding Corneal microdeposists Optic neuropathy |
|
Class III Potassium Channel Blockers: Amiodarone (Cordarone, Pcerone): Drug Interactions |
Quinidine Diogoxin Procainamide Diltiazem Phenytoin Warfarin |
|
Class IV: Calcium Channel Blockers: Verapamil and Diltiazem |
Reduces SA nodal automaticity Delays AV nodal conduction Reduces myocardial contractility Therapeutic uses: 1. Slows heart rate (atrial fibrilation or atrial flutter) 2. Terminate SVT caused by an AV nodal reentrant circuit |
|
Class IV: Calcium Channel Blockers: Berapamil and Diltiazem Adverse Effects |
Bradycardia Hypotension AV block Heart failure Peripheral edema Constipation |
|
Adenosine: Effects on the heart and ECG |
Decreases automaticity in the SA node Slows conduction through the AV node Prolongation of PR interval |
|
Adenosin: Therapeutic use |
Termination of paroxysmal SVT |
|
Adenosine: Adverse effects |
Sinus bardycardia, possible asystole Dyspnea Hypotension Facial flushing. |